| Product Code: ETC9968817 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States saw a significant increase in kyphoplasty import shipments in 2024, with top exporting countries being Switzerland, Brazil, South Korea, China, and Germany. The market displayed a shift towards high concentration, indicating a more focused supply chain. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) from 2020 to 2024 remained strong at 10.97%, highlighting sustained interest and demand in the kyphoplasty market. This data suggests a dynamic landscape with potential opportunities for market players to capitalize on in the coming years.

The United States Kyphoplasty market is experiencing steady growth driven by an increasing prevalence of osteoporosis and vertebral compression fractures among the aging population. Kyphoplasty is a minimally invasive surgical procedure that involves the injection of bone cement into fractured vertebrae to stabilize and reduce pain. Factors such as technological advancements in kyphoplasty procedures, rising awareness about the benefits of minimally invasive surgeries, and a growing demand for quick pain relief solutions are contributing to the market`s expansion. Key players in the US kyphoplasty market include Medtronic, Stryker Corporation, DePuy Synthes, and Globus Medical. The market is also witnessing innovations in product development and strategic collaborations to enhance the adoption of kyphoplasty procedures in the country.
The US Kyphoplasty market is witnessing growth due to an increasing prevalence of osteoporosis and spinal fractures among the aging population. Technological advancements in kyphoplasty procedures, such as the development of minimally invasive techniques and the introduction of new bone cement materials, are driving market growth. Additionally, a rising awareness among patients regarding the benefits of kyphoplasty in reducing pain and improving quality of life is further boosting market demand. Opportunities in the US Kyphoplasty market include expanding the use of kyphoplasty in treating vertebral compression fractures resulting from conditions such as cancer and trauma, as well as focusing on improving patient outcomes and reducing procedure costs to make kyphoplasty more accessible to a larger patient population. Overall, the US Kyphoplasty market is expected to continue growing as the aging population increases and as healthcare providers increasingly adopt advanced kyphoplasty techniques.
The United States Kyphoplasty market faces several challenges, including reimbursement issues as insurance coverage and reimbursement rates for this procedure can vary, leading to financial uncertainties for healthcare providers and patients. Additionally, there is a shortage of trained healthcare professionals with expertise in performing kyphoplasty, which can limit patient access to this treatment option. Another challenge is the competitive landscape, with multiple medical device companies offering kyphoplasty products, leading to pricing pressures and the need for companies to differentiate their offerings. Lastly, there is a lack of awareness among the general population about kyphoplasty as a treatment for vertebral compression fractures, resulting in underutilization of this procedure despite its potential benefits for patients.
The United States Kyphoplasty Market is primarily driven by the increasing prevalence of osteoporosis and spinal fractures among the aging population. The rising awareness about minimally invasive procedures for treating vertebral compression fractures, coupled with advancements in kyphoplasty techniques and technologies, is also fueling market growth. Additionally, the growing adoption of outpatient procedures and the benefits of kyphoplasty such as reduced pain, improved quality of life, and shorter recovery times are contributing to market expansion. Moreover, the availability of favorable reimbursement policies for kyphoplasty procedures in the US healthcare system is further driving the market by making the treatment more accessible and affordable for patients.
The US Kyphoplasty market is impacted by various government policies, including reimbursement regulations by the Centers for Medicare & Medicaid Services (CMS) which affect the pricing and adoption of kyphoplasty procedures. The Food and Drug Administration (FDA) regulates the approval and safety of kyphoplasty devices, ensuring their efficacy and patient safety. Additionally, the Affordable Care Act (ACA) has influenced healthcare coverage and access to kyphoplasty procedures for patients. The government`s focus on value-based care and cost containment measures also shape the landscape of the US Kyphoplasty market, influencing decision-making by healthcare providers and patients. Keeping abreast of these policies is crucial for stakeholders in the kyphoplasty market to navigate regulatory requirements and market dynamics effectively.
The United States Kyphoplasty market is expected to show steady growth in the coming years due to the increasing prevalence of osteoporosis and spine fractures among the aging population. Technological advancements in kyphoplasty procedures and devices, along with the rising awareness about minimally invasive spinal surgeries, will drive market expansion. Additionally, the growing adoption of outpatient procedures and the emphasis on reducing healthcare costs are likely to boost market demand. Key players in the industry are focusing on product innovations and strategic collaborations to capitalize on the expanding market opportunities. However, regulatory challenges and reimbursement issues may pose certain constraints to market growth. Overall, the US Kyphoplasty market is poised for growth, driven by demographic trends and advancements in medical technology.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Kyphoplasty Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Kyphoplasty Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Kyphoplasty Market - Industry Life Cycle |
3.4 United States (US) Kyphoplasty Market - Porter's Five Forces |
3.5 United States (US) Kyphoplasty Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Kyphoplasty Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United States (US) Kyphoplasty Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Kyphoplasty Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of osteoporosis and osteoporotic fractures in the aging population |
4.2.2 Technological advancements in kyphoplasty procedures leading to better patient outcomes |
4.2.3 Growing awareness about minimally invasive surgical techniques for spinal fractures |
4.3 Market Restraints |
4.3.1 High cost associated with kyphoplasty procedures limiting adoption rates |
4.3.2 Reimbursement challenges and insurance coverage limitations |
4.3.3 Regulatory hurdles and compliance requirements impacting market growth |
5 United States (US) Kyphoplasty Market Trends |
6 United States (US) Kyphoplasty Market, By Types |
6.1 United States (US) Kyphoplasty Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Kyphoplasty Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Kyphoplasty Market Revenues & Volume, By Balloon, 2021- 2031F |
6.1.4 United States (US) Kyphoplasty Market Revenues & Volume, By Needle, X- ray Device, 2021- 2031F |
6.1.5 United States (US) Kyphoplasty Market Revenues & Volume, By Cement Mixing, 2021- 2031F |
6.1.6 United States (US) Kyphoplasty Market Revenues & Volume, By Delivery Devices, 2021- 2031F |
6.2 United States (US) Kyphoplasty Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Kyphoplasty Market Revenues & Volume, By Restoring Lost Vertebral Body, 2021- 2031F |
6.2.3 United States (US) Kyphoplasty Market Revenues & Volume, By Spinal Fractures, 2021- 2031F |
6.2.4 United States (US) Kyphoplasty Market Revenues & Volume, By Correction of the Local Kyphosis, 2021- 2031F |
6.3 United States (US) Kyphoplasty Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Kyphoplasty Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Kyphoplasty Market Revenues & Volume, By Ambulatory surgical Centers, 2021- 2031F |
6.3.4 United States (US) Kyphoplasty Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.5 United States (US) Kyphoplasty Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Kyphoplasty Market Import-Export Trade Statistics |
7.1 United States (US) Kyphoplasty Market Export to Major Countries |
7.2 United States (US) Kyphoplasty Market Imports from Major Countries |
8 United States (US) Kyphoplasty Market Key Performance Indicators |
8.1 Average procedure time for kyphoplasty surgeries |
8.2 Number of trained physicians offering kyphoplasty procedures |
8.3 Patient satisfaction rates post-kyphoplasty treatment |
8.4 Adoption rate of minimally invasive spinal fracture treatments |
8.5 Number of research studies and clinical trials on kyphoplasty advancements |
9 United States (US) Kyphoplasty Market - Opportunity Assessment |
9.1 United States (US) Kyphoplasty Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Kyphoplasty Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United States (US) Kyphoplasty Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Kyphoplasty Market - Competitive Landscape |
10.1 United States (US) Kyphoplasty Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Kyphoplasty Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |